Treatment of Insomnia with Unani Medicine Raughan-e-Kahu.

Clinical Validation of Unani Pharmacopoeal formulation Raughan-e-Kahu in Sahar (Insomnia)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015402

Enrollment

100

Registered

2018-08-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system Health Condition 2: G470- Insomnia

Interventions

Intervention1: Raughan Kahu: To be applied locally on fore head before going to bed in the night once daily for one week Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: The patients fulfilling the following criteria will be included in this study: 1. Patients of either sex in the age group 19-70 years. 2. Patients with an insomnia severity index score between 8-21

Exclusion criteria

Exclusion criteria: Any one of the following: 1. Patients having severe and chronic pain due to any underlying disease.

Design outcomes

Primary

Measure	Time frame
improvement in the sign and symptoms of Sahar (Insomnia)Timepoint: one week	—

Secondary

Measure	Time frame
Hematological and biochemical assessments for safetyTimepoint: one week	—

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026